Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CNTB | AMGN | VRTX | REGN | BMY |
| Company | Connect Biopharma Holdings Ltd ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.6100 | 313.23 | 403.70 | 926.94 | 44.10 |
| High | 1.6400 | 313.23 | 403.70 | 958.13 | 44.10 |
| Low | 1.5146 | 313.23 | 403.70 | 926.94 | 44.10 |
| Last | 1.5900 | 313.23 | 403.70 | 957.00 | 44.10 |
| Change | +0.0400 | +1.94 | +2.62 | +19.39 | +0.11 |
| % Change | +2.58% | +0.62% | +0.65% | +2.07% | +0.25% |
| Volume | 58,500 | 8,173 | 1,821 | 547,300 | 13,607 |
| 20-Day Average Volume | 94,585 | 2,555,754 | 985,096 | 518,580 | 13,852,160 |
| Previous Close | 1.5500 | 311.29 | 401.08 | 937.61 | 43.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5660 | 274.47 | 398.40 | 909.87 | 47.11 |
| 20-Day Raw Stochastic | 30.69% | 84.87% | 79.61% | 98.64% | 9.19% |
| 20-Day Relative Strength | 52.80% | 72.78% | 49.37% | 59.08% | 29.94% |
| Weighted Alpha | +7.69 | +35.88 | +15.38 | +26.69 | -35.98 |
| Today's Opinion | 96% Buy | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 80% Buy | 24% Buy | 8% Buy | 48% Buy | 100% Sell |
| Last Month's Opinion | 100% Buy | 8% Sell | 40% Buy | 56% Buy | 16% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +18.66% since 04/26/24 | +13.33% since 04/29/24 | +1.89% since 04/29/24 | +8.36% since 04/26/24 | -1.21% since 04/29/24 |
| Low | 1.3100 on 04/29/24 | 272.35 on 04/30/24 | 391.70 on 04/30/24 | 883.20 on 04/29/24 | 43.33 on 05/02/24 |
| High | 1.6400 on 05/03/24 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 958.13 on 05/03/24 | 44.76 on 04/30/24 |
| 1-Month | |||||
| %Chg | -25.35% since 04/03/24 | +16.03% since 04/05/24 | -0.73% since 04/05/24 | +0.64% since 04/03/24 | -14.07% since 04/05/24 |
| Low | 1.2801 on 04/22/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 2.2899 on 04/08/24 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 962.20 on 04/04/24 | 51.68 on 04/09/24 |
| 3-Month | |||||
| %Chg | +51.43% since 02/02/24 | -0.90% since 02/06/24 | -2.99% since 02/06/24 | +1.25% since 02/02/24 | -10.48% since 02/06/24 |
| Low | 0.9800 on 02/23/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 2.6600 on 04/02/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +5.30% since 11/03/23 | +14.81% since 11/06/23 | +4.65% since 11/06/23 | +17.15% since 11/03/23 | -16.46% since 11/06/23 |
| Low | 0.6777 on 12/14/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 2.8400 on 11/17/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 87,611 | 166,968,480 | 103,662,736 | 105,042,232 | 89,172,128 |
| Shares Outstanding, K | 55,101 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -59,500,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | N/A | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | N/A | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | -0.49 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.20 on 02/05/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 04/09/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.94 | 29.77 | 25.27 | 41.62 |